DarioHealth regains Nasdaq minimum bid price compliance; deficiency closed

DarioHealth Corp.

Received Nasdaq notice on Sep 12, 2025 confirming compliance with Rule 5550(a)(2).
Closing bid price at or above $1.00 for 10 consecutive days (Aug 28 to Sep 11, 2025).
The matter is now closed; no further action required.

item 8.01

Source: SEC EDGAR

accession 0001104659-25-089629

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.